Oruka Therapeutics, Inc. (ORKA) — Stock Score Summary

Oruka Therapeutics, Inc. (ORKA) has a MoatMap StockRank of 61/100 based on Quality (45/100), Value (37/100), and Momentum (64/100) factor scores. The current signal is HOLD. Oruka Therapeutics is a pre-revenue biotech company with high development risk and no commercialized products, failing all quality and margin of safety criteria.

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutic candidates to address specific diseases with significant unmet medical needs. The company's potential competitive advantage will be derived from the efficacy and safety of its proprietary pipeline assets as they advance through clinical development.

Key Financial Metrics

Price$66.93
Market Cap$3.5B
P/E (Forward)-25.29
Price/Book6.46
Return on Equity-27.3%
Return on Invested Capital-22.3%
Debt/Equity0.37
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-56M

Oruka Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Oruka Therapeutics, Inc.’s (ORKA) StockRank?
MoatMap’s StockRank for Oruka Therapeutics, Inc. (ORKA) is 61/100, with a Hold signal. It is a composite of Quality (45), Value (37), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does Oruka Therapeutics, Inc. have an economic moat?
Oruka Therapeutics, Inc. (ORKA) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Oruka Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Oruka Therapeutics, Inc. (ORKA) is Hold, based on a StockRank of 61/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Oruka Therapeutics, Inc. in?
Oruka Therapeutics, Inc. (ORKA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksORKA deep dive reportAI ChampionsHow we score stocksSense-check another stock